Evidence map›Paper›PMID 39975274›Full record

ArticlebioRxiv : the preprint server for biology2025

Powerful and accurate case-control analysis of spatial molecular data.

Yakir Reshef, Lakshay Sood, Michelle Curtis, Laurie Rumker, Daniel J Stein, Mukta G Palshikar, Saba Nayar, Andrew Filer, Anna Helena Jonsson, Ilya Korsunsky and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yakir ReshefCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0001-6463-4203
Lakshay SoodCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Michelle CurtisCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-6843-4839
Laurie RumkerCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0001-5522-3402
Daniel J SteinCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-9442-2604
Mukta G PalshikarCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-1179-7903
Saba NayarNIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and Department of Inflammation and Ageing, College of Medicine & Health, University of Birmingham, Birmingham, UK.ORCID 0000-0002-4350-110X
Andrew FilerNIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and Department of Inflammation and Ageing, College of Medicine & Health, University of Birmingham, Birmingham, UK.ORCID 0000-0001-8164-6249
Anna Helena JonssonUniversity of Colorado Anschutz Medical Campus, Division of Rheumatology, Aurora, CO, USA.ORCID 0000-0002-9558-2474
Ilya KorsunskyCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.
Soumya RaychaudhuriCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-1901-8265

Funding

Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
MECHANISMS OF ARTHRITIC &DERMATOLOGY DISORDERST32AR007530 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Michael B. Brenner, Ellen M Gravallese · 1986 to 2026
$10.4M
Integrative analysis of high dimensional tissue molecular data to define key biological systems in autoimmune diseases (SBC)UC2AR081023 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Soumya Raychaudhuri · 2022 to 2026
$4.8M
Integrative modelling of single-cell data to elucidate the genetic architecture of complex diseaseR01HG013083 · NHGRI · DANA-FARBER CANCER INST · PI ALEXANDER GUSEV, ALKES L PRICE · 2024 to 2026
$1.5M
Integrative modelling of single-cell data to elucidate the genetic architecture of complex diseaseR56HG013083 · NHGRI · DANA-FARBER CANCER INST · PI GUSEV, ALEXANDER, PRICE, ALKES L · 2023 to 2023
$400k
DISSECTING THE SPATIAL HETEROGENEITY OF SYNOVIAL INFLAMMATION IN RHEUMATOID ARTHRITISK08AR085165 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Yakir Abraham Reshef · 2025 to 2026
$340k
Characterizing the Genomic Basis of Immune-Mediated Resilience Against Tuberculosis in an Admixed Peruvian PopulationF30AI157385 · NIAID · HARVARD MEDICAL SCHOOL · PI RUMKER, LAURIE ANN · 2021 to 2024
$178k
NHGRI NIH HHS R01 HG013083NHGRI NIH HHS R56 HG013083NHGRI NIH HHS T32 HG002295NIAID NIH HHS F30 AI157385NIAMS NIH HHS K08 AR085165NIAMS NIH HHS T32 AR007530NIAMS NIH HHS UC2 AR081023NIGMS NIH HHS T32 GM144273
6 · The paper itself

Abstract

As spatial molecular data grow in scope and resolution, there is a pressing need to identify key spatial structures associated with disease. Current approaches typically make restrictive assumptions such as representing tissue regions by local abundances of manually typed, discrete cell types, or representing samples in terms of abundances of manually called, discrete spatial structures; this risks overlooking important signals. Here we introduce variational inference-based microniche analysis (VIMA), a method that combines deep learning with principled statistics to discover associated spatial features with greater flexibility and precision. VIMA trains an ensemble of variational autoencoders to extract numerical "fingerprints" from small tissue patches that capture their biological content. It uses these fingerprints to define a large number of data-dependent "microniches" - small, potentially overlapping groups of tissue patches with highly similar biology that span multiple samples. It then meta-analyzes across the autoencoders to identify microniches whose abundance correlates with case-control status while controlling for multiple testing. We show in simulations that VIMA is well calibrated. We then apply VIMA to spatial datasets spanning three different diseases and spatial modalities: a 7-marker immunofluorescence (IF) microscopy dataset in rheumatoid arthritis (RA), a 52-marker CO-Detection by indEXing (CODEX) dataset in ulcerative colitis (UC), and a 140-gene spatial transcriptomics dataset in dementia. In each case, we recapitulate known biology and identify novel spatial features of disease that were not discoverable with current state-of-the-art methods.

Identifiers

PMID39975274
PMCPMC11839118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.